Serstech
17.9.2026 18:40:00 CEST | Globenewswire | Press release
Serstech receives 10.7 MSEK order from US partner WS Darley and co
Serstech receives 10.7 MSEK order from US partner WS Darley and co
Serstech has received an order from its US partner WS Darley and co valued at 10.7 MSEK. The order comprises instruments and software and will be delivered and invoiced during the fourth quarter of 2026. The end customer is the US Army.
For further information, please contact:
Stefan Sandor,
CEO, Serstech AB Phone: +46 739 606 067
Email: ss@serstech.com
or
Arve Nilsson,
Chairman of the Board, Serstech AB Phone: +45 40 35 82 65
Email: arve.nilsson@serstech.com
or visit: www.serstech.com
This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 18:40 CET on September 17, 2026.
Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).
About Serstech
Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.
Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CGTN11.10.2026 14:03:56 CEST | Pressemeddelelse
CGTN: Sådan bruger Kina digital teknologi til at styrke kvinder globalt
F. Hoffmann-La Roche Ltd10.10.2026 23:40:00 CEST | Press release
Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Chery Group10.10.2026 18:51:33 CEST | Press release
Evolving Luxury and Intelligence: LUXEED Set to Launch Global Media Drive
EXEED10.10.2026 17:56:39 CEST | Press release
The Pulse Lives on with 550,000 Users: Countdown to the 2026 EXEED International User Summit
CGTN10.10.2026 11:47:10 CEST | Press release
CGTN: How China uses digital tech to empower women globally
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom